Ashish Bose coined the term BIMARU in a paper to then prime minister Rajiv Gandhi in the 1980s to highlight the economic backwardness of Bihar, Madhya Pradesh, Rajasthan and Uttar Pradesh. He tells Somesh Jha he is not inspired by the Planning Commission’s bogus poverty figures. He says it is time the commission wound up. Excerpts: * You coined the term 'BIMARU', but these states performed well in alleviating poverty in...
More »SEARCH RESULT
Punjab’s new agro policy will be a drain on hope -Chander Suta Dogra
-The Hindu Groundwater meets three quarters of the State's farming needs The Punjab State Farmers Commission recently published a draft new agriculture policy for the State that envisages substantial crop diversification from paddy and wheat staples that the State has been growing since the sixties. The draft policy, currently being debated in agriculture circles, is the first serious road map to steer Punjab's agriculture towards a new dynamic, necessitated by a sharp...
More »Sen vs Bhagwati: Parallels from an earlier titanic clash-Rupa Subramanya
-The Business Standard Can Bhagwati-Sen debate bring the same change as Hayek-Keynes duel in the US in 1932 At a time of economic crisis, a distinguished group of economists wrote a letter to a major newspaper, making a case for increased government involvement in the economy. A few days later, an equally distinguished group of economists wrote a letter to the same newspaper, arguing against the first lot. No, this...
More »Bhagwati versus Sen: What's going on?-Mihir S Sharma
-The Business Standard 7 things you should know in the Bhagwati vs Sen slugfest Jagdish Bhagwati and Amartya Sen are the two Indian economists who are most respected for their work. Both have worked on a broad spectrum of issues, though Sen is best known for his work on public choice and development and Bhagwati for his work on trade. They are both liberal, neoclassical economists, who support deregulation and disapprove of...
More »Let the science decide
-The Hindu That the Union Health Ministry takes critical decisions affecting a large number of people without any scientific basis does not portend well for public health in India. Neither the ban imposed on the oral anti-diabetes drug pioglitazone on June 18 nor its revocation a month later with a requirement that the medicine be sold with a boxed warning highlighting the adverse side-effect of bladder cancer was based on any...
More »